Abstract
Probiotics are live microbial cultures which enhance the beneficial gut microflora to improve the overall health of the host. It is a rising field in dairy food industry with significant growth potential. Probiotic food supplements have attracted a lot of attention and revealed a remarkable growth in this field. Various bacteria, yeast, and molds can be used as probiotics, but most commonly used microorganisms are lactic acid bacteria (LAB). LAB is involved in the fermentation of dairy products, foods, and beverages and produces lactic acid as the end product of fermentation. Among LAB, most commonly used bacteria which exhibit excellent probiotic properties belong to Lactobacillus and Bifidobacterium genus. These bacteria produce a variety of compounds such as organic acids (lactic acid and acetic acid), antimicrobial compounds (bacteriocins), nutraceuticals, vitamins, enzymes, etc. Probiotics are also consumed in combination with prebiotics known as synbiotics. Prebiotics are nondigestible carbohydrates, which pass through the small intestine in unmetabolized form and undergo fermentation in the large intestine. The fermentation products act as an energy source for indigenous gut microflora. The food products containing probiotics and prebiotics result in the enhancement of the microflora which promotes the overall gut health. This chapter enclosed a brief knowledge of different probiotic strains, probiotic foods, and their health applications.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Probiotics are microorganisms that are involved in providing health benefits to the consumer, when administrated in adequate amounts (Hill et al. 2014). As probiotics exhibit various health benefits, these are used for the production of food products like yogurt, fermented milk, etc. Lilly and Stillwell described the term probiotics and defined as the substances which are secreted by one microbe and in turn affect the other microbes. Fermented milk was the first recorded probiotic food. Elie Metchnikoff published his book The Prolongation of Life which boosted the research in probiotic area. After experimenting in the Bulgarian peasants, he concluded that longevity in them was due to consumption of large amounts of sour milk. This milk contains LAB which removes the pathological reactions like autotoxication by the gut’s normal flora (Metchnikoff 1907). After this, the researchers started working on LAB importance in human health and diseases. Probiotics include bacteria, nonpathogenic yeast, and molds (Ouwehand et al. 2002). LAB produce lactic acid as their end product of fermentation and are ordinarily used for the production of yogurt, fermented milk, or other fermented foods. These are gram-positive, oxidase- and catalase-negative, sporulating rods and cocci. The genera comprise of Lactobacillus, Leuconostoc, Lactococcus, Streptococcus, Pediococcus, Enterococcus, Carnobacterium, Sporolactobacillus, Bifidobacterium, Oenococcus , Sporolactobacillus, Vagococcus, Tetragenococcus, Weissella, etc. These are widely spread in nature and also found in many food products as well as in oral, genital, and intestinal cavity of animals and human. Lactobacillus is the most important genus of LAB which include more than 80 species, and these are present in milk and dairy products like cheese and yogurt. Most microorganisms which are used as probiotics belong to genera Lactobacillus, Enterococcus, and Bifidobacterium (Holzapfel and Wood 2014). Some of strains which are showing good probiotic properties are Lactobacillus acidophilus, L. lactis, L. casei, L. plantarum, L. helveticus, L. salivarius, L. johnsonii, L. bulgaricus, L. reuteri, L. rhamnosus, L. delbrueckii, L. fermentum, Bifidobacterium bifidum, B. longum, B. breve, Streptococcus thermophilus, Enterococcus faecium, and Saccharomyces boulardii.
Various beneficial effects produced by LAB consumption involve improvement of the health of the intestinal tract, increasing the capability of the immune system, synthesis and increase of availability of the nutrients, reduction of the symptoms of lactose intolerance, decreasing the frequency of the allergy in the individuals who are susceptible to allergy, and reducing the risk of cancers in the consumer (Goyal et al. 2013, Savadago et al. 2006). The mechanisms of the action of probiotic by which they employ their effects are largely unidentified but may involve in the modification of the pH of the gut. They decrease the concentration of the pathogens by producing antimicrobial compounds and by competing for the binding sites and receptor sites for the growth factors and for the nutrients available to the pathogen. The food products which contain probiotics and prebiotics affect the functionality of the foods, which results in the enhancement of the microflora that promotes the gut health. The probiotic bacterial species increases the growth of the beneficial microorganisms, removes of the harmful bacteria, and supports the innate immunity of the body. A probiotic strain should fulfill the following selection criteria: safety, viability during storage, acid tolerant, bile tolerant, other epithelial cells of the gut, and able to colonize the intestinal tract, stimulate immune responses, and modulate normal microflora (Saad et al. 2013; Lee et al. 2014). The viability and functionality cannot be lost during their technological integration into food products, and it must not involve the creation of unpleasant textures or flavors. The technological, operational, and safety characteristics are accepted for the selection of the probiotics.
Processes like food digestion and nutrient integration occur in the small intestine, whereas the indigestible carbohydrates known as prebiotics can cross the small intestine, and, thus, they pass into the large intestine for the stimulation of the growth of probiotic bacteria. Prebiotics can be defined as nondigestible food products which stimulate growth and activity of bacteria in the host’s intestine. So, these are dietary substances which support the growth of wanted bacteria over the unwanted one present in the gut. Prebiotics mainly include breast milk oligosaccharides, short-chain carbohydrates, inulin, galacto-oligosaccharides, oligofructose, and lactulose. Food containing prebiotics are garlic, wheat, bananas, honey, leeks, onion, etc. Synbiotics are the combination of probiotics and prebiotics. These contain probiotics which are beneficial bacteria and prebiotics which are indigestible products for the enhancement of growth of good bacteria. Fermented dairy products, kefir, and yogurt are the examples of the synbiotic food products. The most common synbiotics include fructooligosaccharides (FOS) and bifidobacteria, inulins and Lactobacillus GG, and bifidobacteria and lactobacilli with fructooligosaccharides. Nowadays metabolic engineering techniques for designing new probiotics in food industry have gained a lot of attention (Singh and Shukla 2014). Genetic modification of microbes involves the introduction of desired genes that may have a positive impact on the food industry (Gupta and Shukla 2015).
2 Probiotic Foods
Most commonly used probiotic product is yogurt. In spite of this, cheese, milk either fermented or unfermented, smoothies, juice, nutrition bars, cereals, and infant formula feed all are examples of probiotic food (Ranadheera et al. 2010). Along with food, probiotics can also be available in the form of liquid, powder, gel, granules, paste, capsules, sachets, drugs, and as dietary supplements. All these forms contain a large number of bacteria which remain in a stable condition. These forms of products are more convenient as we can deliver a large number of bacteria from manufacturer to customer in stable condition. There are various products made by different companies using different strains of probiotics. These products have various clinical or therapeutic applications. The use of probiotics in food or other products depends on many factors like stability of product, humidity, pH, age of customer, quantity or number of bacteria used, etc. These products are helpful for all age groups like children, infants, and old age. The aim of using these microbes as probiotics is mainly to increase the beneficial flora of the host.
In the United States, dairy products (e.g., fermented milk and yogurt) are the food products that contain the probiotic exclusions. LAB are associated with the fermented milk (Shah 2015). The most commonly used bacteria in dairy products (containing probiotics) include Lactobacillus and Bifidobacterium (Backhed 2012). Probiotics commonly are not the colonizers of the GI tract for long term, but they can stick provisionally to the epithelial layer. They remain metabolically active, although they divide very slowly in the intestine. Milk and milk products contain probiotic bacteria, which improve the beneficial microbiota in the intestine (Isolauri et al. 2001). Probiotics are a group of microorganisms that are involved directly in increasing the resistance of bacteria against intestinal pathogens and thus are involved in the prevention of the diseases. Probiotic bacteria involved in the production of a variety of compounds, which shows an inhibitory effect to the growth of pathogenic microorganisms, include bacteriocins, reuterin, and organic acids such as acetic acids and lactic acids. For the delivery of probiotic microorganisms in the body, food is the common medium. Probiotic microorganisms that are given by food systems have to fulfill some conditions like they have to first survive during the transfer through the upper gastrointestinal tract and then survive in the gut to produce beneficial effects to the host. Fermented foods can have probiotics, prebiotics, or both, and they are associated with good health. Yogurt is a well-known probiotic used today. It contains a very good nutritional value and provides health benefits to the host. The various factors that affect the growth of probiotic bacteria are pH, the presence of hydrogen peroxide and dissolved oxygen, buffering capacity, and concentration of metabolites (lactic acid, acetic acid, etc.).
3 Probiotic Microorganisms
Various bacteria, yeast, and molds can be used as probiotics, but most commonly used microorganisms are bacteria, and among bacteria, LAB are more popular. An overview of applications of LAB is given in Fig. 6.1.
Probiotics may be formed by a group of different strains or single bacterium. Probiotic preparations consist of specific strains of Lactobacillus, Streptococcus, and Bifidobacterium either alone or in combination. These three genera are considered to be safe and might be capable of preventing the overgrowth of pathogenic organisms as these are important components of the gastrointestinal flora. The commonly used probiotic bacteria are summarized in Table 6.1.
4 Probiotics: Mechanism of Action
Probiotics exhibit numerous and various effects to the host. The probiotic bacteria decrease the luminal pH resulting in inhibition of the establishment of pathogenic bacteria, inhibit the bacterial attack and the attachment of pathogenic bacteria to epithelial cells, and produce the antimicrobial compounds, e.g., defensins and bacteriocins, hydrogen peroxide, and organic acids. The action of LAB with the lymphoid cells in the gut and cells of the gastrointestinal tract increases the immune response of the gut against pathogens. Development of the function of mucosal barrier against ingested pathogens is done by increasing the production of mucus by the variation in the phosphorylation of proteins in tight junctions and cytoskeleton. The probiotic bacteria strive for the binding sites of epithelial layer with the pathogenic bacteria and inhibit the multiplication of strains like E. coli and Salmonella. Probiotic bacteria cooperate with the gut epithelial cells, directly (via compounds of cells like lipoteichoic acids, cell-surface polysaccharides, and DNA) or indirectly (by bioactive metabolite production). Probiotics influence the acquired and the innate immunity, thus having an important role in the human diseases. Probiotics remove the neoplastic cells of the host. Furthermore, the production of B-lymphocytes and antibody results in increase of the secretion of IgA and the vaccination response. Currently, probiotics prevent and reduce the harshness of respiratory infections, by increasing IgA in the bronchial mucosa (Reid 2016).
5 Applications of Probiotics in Human Health
There are several health benefits of probiotics:
-
Increase nutritional status of the individual
-
Increase vitamins, minerals, and trace elements availability to the body
-
Help in secretion of digestive enzyme, e.g., secretion of β-galactosidase
-
Prevention and treatment of diarrhea due to infection, traveler’s diarrhea, acute viral diarrhea in children, diarrhea associated with overdose of antibiotics, and irradiation exposure diarrhea
-
Lowers down body cholesterol
-
Improvement of the immune system
-
Increase large intestinal motility that helps to relief constipation
-
Maintain mucosal integrity
-
Maintain intestinal microbes by antimicrobial activity
-
Decrease symptoms of lactose intolerance
-
Prevent food-borne allergies
-
Exhibit anticarcinogenic activities
An overview of health benefits of probiotic microorganisms has been given in Table 6.2.
5.1 Treatment of Diarrhea
Probiotics have a beneficial role in the prevention of diarrhea. It has been established that various probiotic strains like L. rhamnosus GG, L. casei, L. reuteri, Bifidobacterium spp., S. boulardii, etc., are useful in decreasing the duration and severity of diarrhea (Isolauri 2004). The duration of acute diarrhea can be decreased by the oral administration of probiotics in children who are approximately of 1 day. The timing of administration is also very important for the action of probiotics. In antibiotic-associated diarrhea, L. rhamnosus GG and S. boulardii are effective in children or in adults who receive antibiotic therapy. The causative agent of antibiotic-associated diarrhea is C. difficile, which occurs after antibiotic treatment. It is an indigenous resident of a healthy intestine in low numbers. The antibiotic treatment may lead to disruption of healthy gut microflora, which results in increasing the number of C. difficile, which leads to diarrhea symptoms (Vasiljevic and Shah 2008; Ollech et al. 2016). Probiotic administration is very effective in the restoration of gut microflora. It is observed that L. casei, B. longum, L. plantarum, B. breve, L. acidophilus, B. infantis, L. delbrueckii, and S. thermophilus are very effective in the treatment of diarrhea caused by radiations. L. casei DN-114001 is very effective in the prevention of the radiation-induced diarrhea (Giralt et al. 2008). Probiotics are also able to prevent traveler’s diarrhea and diarrhea caused by rotavirus (Vanderhoof 2000). It inhibits rotavirus adherence by modifying glycosylation state of epithelial cell receptors by excreting soluble factors (Freitas et al. 2003). Probiotic microorganisms prevent the diarrhea caused by microbes either by competitive binding to gut epithelial cells or by producing antimicrobial bacteriocins such as nisin. Also the probiotic strains can modulate the innate immune response (Braat et al. 2004).
5.2 Eradication of Helicobacter pylori Infections
Probiotic strains produce a variety of antimicrobial substances such as organic acids (acetic acid and lactic acid), bacteriocins, hydrogen peroxide, fatty acids, and antifungal peptides. The organic acids lower the pH of the gastrointestinal tract, which has an inhibitory effect on pathogens. H. pylori is an intestinal pathogen which is associated with peptic ulcers, chronic gastritis, and gastric cancer (Plummer et al. 2004; Fallone et al. 2016). The lactic acid produced by L. salivarius was found to inhibit H. pylori growth in vitro (Aiba et al. 1998). Modulating the diet by adding the probiotics may reduce the bacterial load and inflammation (Khulusi et al. 1995). L. casei Shirota, L. gasseri OLL2716, and L. johnsonii La1 were found to reduce the colonization and inflammation caused by H. pylori (Felley et al. 2001, Sgouras et al. 2004). A study reported by a group of researchers concluded that regular intake of probiotic yogurt containing mixture of L. acidophilus La5 and B. animalis Bb12 may suppress the infection by decreasing the bacterial load (Wang et al. 2004).
5.3 Cardiovascular Diseases
Cardiovascular diseases include coronary artery diseases, stroke, hypertensive heart diseases, etc.
Cholesterol-rich diet increases the risk of coronary heart diseases by increasing the serum cholesterol level. Mann and Spoerry (1974) first time reported the decreased serum cholesterol level due to consumption of fermented milk. Regular intake of probiotics may decrease the concentration of serum cholesterol level. A group of researchers demonstrated the role of L. plantarum, B. longum, E. faecium, and Propionibacterium freudenreichii in hypercholesterolemia and cardiovascular diseases (Kiatpapan et al. 2001; Xiao et al. 2003; Nguyen et al. 2007).
5.4 Cancer Prevention
Some fermented foods such as yogurt, dahi, sauerkraut, kefir, kimchi, and fermented milk comprise of anticarcinogenic activities (Mohania et al. 2013, Kwak et al. 2014). Regular intake of probiotic yogurt containing Lactobacillus and Bifidobacterium could reduce the risk of cervical, bladder, and colon cancer (Chandan and Kilara 2013). A study has been reported for the treatment of cancer by using kefir (Yanping et al. 2009). Fermented milk contains L. acidophilus which activates the immune system of the host and removes procarcinogens (Macouzet et al. 2009). A possible mechanism of cancer control by probiotic could be in the following ways: probiotics can cause inhibition of tumor cells and suppression of bacteria that produces such enzymes, which catalyze procarcinogen conversion to carcinogens. Also, they can destroy the carcinogens.
5.5 Prevention of Allergy
The prevention of atopic dermatitis (allergy) is the strongest evidence when some probiotics are supplemented to the newborns (up to the age of 6) and to pregnant mothers. Some specific probiotic strains are very operative for the treatment of the patients suffering from atopic eczema. B. bifidum, B. lactis, E. coli, and L. lactis have been reported for their beneficial roles in the treatment of eczema and food allergies (Niers, et al. 2009). Hong et al. (2010) reported anti-allergic effect of L. kefiranofaciens M1, isolated from kefir grains. Lactobacillus strain isolated from fermented kimchi has ability to modulate the balance of Th1/Th2 by producing interferons IL-12 and IFN-γ which reduce symptoms of food allergies and atopic dermatitis (Won et al. 2011; Koletzko 2016). Omega-3 fatty acid-rich fermented fish oil alleviates the allergic sensitization (Han et al. 2012).
5.6 Irritable Bowel Syndrome
An intestinal disorder with symptoms of belly pain, gas, diarrhea, and constipation is known as irritable bowel syndrome. L. reuteri may be involved in the improvement of symptoms after 1-week treatment. In summary, there is a data which suggests that some probiotics such as B. infantis 35624, E. coli DSM17252, and B. breve may be involved in the improvement of symptoms (Enck et al. 2009).
5.7 Inflammatory Bowel Disease
The major symptoms of inflammatory bowel disease (IBD) are diarrhea, abdominal pain, and gastrointestinal bleeding (Hanauer 2006). Ulcerative colitis and Crohn’s disease are two categories of IBD, which are relapsing, remitting, and chronic diseases. Ulcerative colitis is a Th2-driven immune response characterized by production of interleukin (IL)-5, a pro-inflammatory cytokine. Further, Crohn’s disease is Th1 immune response with a predominant increase in IL-12, interferon (IFN)-g, and tumor necrosis factor (TNF). Probiotic L. acidophilus, E. coli Nissle 1917, and Bifidobacterium have shown positive effects on ulcerative colitis (Imaoka et al. 2008). In vitro studies of IBD have shown that probiotic L. rhamnosus GG can modulate the host immune system by carrying out downregulation of TNF (Zhang et al. 2005). Similarly, in vivo studies on animals indicated the beneficial role of B. lactis Bb12 in immune modulation and prevention of intestinal inflammation (Ruiz et al. 2005). A study revealed that fermented milk consumption could prevent the effect of ulcerative colitis (Ishikawa et al. 2003). In a similar study, B. animalis strains showed the reduction of IBD symptoms (Guyonnet et al. 2007).
5.8 Lactose Malabsorption
The condition of incomplete digestion of lactose (principle carbohydrate of milk) is known as lactose malabsorption. Due to deficiency of β-galactosidase enzyme, lactose does not completely break into glucose and galactose in the small intestine and passes to the large intestine (Shah 2015). The undigested lactose is fermented by the indigenous microflora of the large intestine, which results in production of short-chain fatty acids and gases (CO2, CH4, H2). The gas production causes gastrointestinal disturbances such as abdominal pain, diarrhea, and flatulence (Granato et al. 2010). Probiotic microorganisms are extensively known to alleviate the symptoms of lactose malabsorption. Studies have been reported that Bifidobacterium may increase the production of β-galactosidase enzyme which can improve lactose digestion in the small intestine (Parracho et al. 2007). Furthermore, consumption of yogurt containing B. animalis, L. delbrueckii subsp. bulgaricus, and S. thermophilus could improve the gut microflora and reduce the symptoms of lactose malabsorption (Shah et al. 2013). Kefir is also an excellent source of β-galactosidase enzyme for persons suffering from lactose intolerance (Hertzler and Clancy 2003).
5.9 Immune System Modulation
Human immune system is a complex system which includes two types of immunity: innate (natural) and adaptive (acquired). The innate immunity of an individual is by birth and acts as the first line of defense to external stimulus. Natural killer cells are the key components of innate immunity and are involved in recognition and lysis of tumor cells, virus-infected cells, etc. On the other hand, the adaptive immunity is acquired through the lifetime of an individual. Both the immunities are key aspects of understanding the mechanisms of autoimmunity, allergy, vaccination, and carcinogenicity. The epithelial cells of the intestine remain in direct contact with gut microflora and interface with the immune system (Vasiljevic and Shah 2008). The epithelial cell-surface receptors recognize probiotics, and they beneficially affect the immune system (Isolauri et al. 2001). Dairy products containing probiotic bacteria could stimulate the mucosal immune system and increase the IgA+ cell count, which acts as a first line of defense (Lollo et al. 2013). Numerous studies reported immune system modulation by bifidobacteria. In a study, infants suffering with necrotizing enterocolitis were fed with breast milk containing B. infantis and L. acidophilus. As a result of probiotic intake, the severity of disease is reduced (Lin et al. 2005). A similar study revealed that fermented milk and yogurt contain some nonbacterial components such as peptides and fatty acids which are produced during fermentation. These components were shown to modulate the immune system. Probiotic L. plantarum DSMZ 12028 and Bacillus circulans PB7 were also reported for immune modulatory effect (Cammarota et al. 2009).
6 Application in Animal and Plant Health
The microflora of the gastrointestinal tract of the animals is very important for the normal digestion. Probiotics attach to the mucus wall and adjust with the immune response of the host and then compete with the pathogenic microorganisms. Probiotics enhance the immune responses by the uptake of necessary nutrients for the body and are involved in the removal of pathogenic bacteria and increase of growth of nonpathogenic strains. The soil becomes more fertile by the presence of beneficial bacteria and fungi in the soil. Plant probiotic products could be used as biopesticides, biofetilizers, and plant stimulators. Probiotic bacteria also influence the hormonal equilibrium in plants (Berg 2009). Some commercial plant products that use probiotic cultures are Kodiak (Bacillus subtilis GB03), YiedShield (B. pumilis GB34), Rotex (Phlebiopsis gigantea), Cedomon (Pseudomonas chlororaphis), etc. (Song et al. 2012).
7 Conclusion and Future Perspectives
In this chapter, there is a brief knowledge of applications of different probiotic strains in human health. Effectiveness of probiotics could be improved by using the mixture of probiotics and prebiotics. For this purpose, Bifidobacteria can act as a valuable adjuvant for improvement of probiotic functionality. A person acquires his/her microflora at the time of birth from his/her mother’s health as well as from surroundings. The presence of good microflora leads to good health conditions. External factors such as foreign microorganisms, diseases, and excess use of antibiotics may lead to disturbance of gut microflora. Probiotic microorganisms are able to restore the microflora which imparts various health benefits to the consumer. Fermented products such as yogurt, fermented milk, curd, kimchi, kefir, etc., are a good source of probiotics. In addition, researchers have reported various studies of probiotic applications in the treatment, prevention, and management of diseases. So, there is a requirement of designing new and improved form of probiotics for their applications in the field of food and health.
Effects of probiotics could be improved by the development of nano-encapsulated probiotics (the shelf life of the product can be enhanced by the encapsulation) by using nanotechnology applications. The WHO also suggested that probiotics will be the most important tool to fight against many infectious and noninfectious diseases in place of antibiotics which show many adverse effects like antibiotic resistance. Antibiotic resistance cases can be treated by probiotics that is termed as microbial interference therapy. Thus, that time is not so far when probiotics will become the most commonly used therapeutic tool by medical personnels. Recent advancement in technology helps to isolate and colonize microorganisms to determine their specific therapeutic properties and uses. In countries like Japan, Europe, and Australia, probiotics and their related products currently occupy the largest sector in the food market. The European Commission has sponsored research projects for the safety and efficacy of the products.
References
Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y (1998) Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93:2097–2101
Anderson JW, Gilliland SE (1999) Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18:43–50
Backhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM et al (2012) Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12:611–622
Berg G (2009) Plant-microbe interactions promoting plant growth and health: perspectives for controlled use of microorganisms in agriculture. Appl Microbiol Biot 84:11–18
Bernet MF, Brassart D, Neeser JR, Servin AL (1994) Lactobacillus acidophilus LA-1 binds to cultured human intestinal cell-lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35:483–489
Braat H, de Jong EC, van den Brande JM, Kapsenberg ML, Peppelenbosch MP, van Tol EA, van Deventer SJ (2004) Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J Mol Med 82:197–205
Cammarota M, De Rosa M, Stellavato A, Lamberti M, Marzaioli I, Giuliano M (2009) In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity. Int J Food Microbiol 135:90–98
Chandan RC, Kilara A (2013) Manufacturing yogurt and fermented milks, 2nd edn. Wiley, Chichester, p 477
Enck P, Zimmermann K, Menke G, Klosterhalfen S (2009) Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z. Gastroenterol 47:209–214
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK (2016) The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gasteroenterol 151:51–69
Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann BP, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13:25–29
Freitas M, Tavan E, Cayuela C, Diop L, Sapin C, Trugnan G (2003) Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 95:503–506
Giralt J, Regadera JP, Verges R, Romero J, de la Fuente BA, Villoria J, Cobo JM, Guarner F (2008) Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results frommulticenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 71:1213–1219
Goyal S, Raj T, Banerjee C, Imam J, Shukla P (2013) Isolation and ecological screening of indigenous probiotic microorganisms from curd and chili sauce samples. Int J Probiotics Prebiotic 8:91
Granato D, Branco GF, Nazzaro F, Cruz AG, Jose AF (2010) Functional foods and nondairy probiotic food development: trends, concepts, and products. Compr Rev Food Sci Food Saf 9:292–302
Gupta SK, Shukla P (2015) Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications. Crit Rev Biotechnol 18:1–10
Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C (2007) Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 26:475–486
Hajela N, Ramakrishna BS, Nair BG, Abraham P, Gopalan S, Ganguly NK (2015) Gut microbiome, gut function, and probiotics: implications for health. Ind J Gastroenterol 34:93–107
Han S, Kang G, Ko Y, Kang H, Moon S, Ann Y, Yoo ES (2012) Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cells. BMC Immunol 13:44
Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12:3–9
He T, Priebe MG, Zhong Y, Huang CM, Harmsen HJ, Raangs GC, Antoine JM, Welling GW, Vonk RJ (2008) Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J Appl Microbiol 104:595–604
Hertzler SR, Clancy SM (2003) Kefir improves lactose digestion and tolerance in adults with lactose maldigestion. J Am Diet Assoc 103:582–587
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014) Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514
Hong W, Chen Y, Chen M (2010) The antiallergic effect of kefir Lactobacilli. J Food Sci 75:244–253
Holzapfel WH, Wood BJB (2014) Lactic acid bacteria: biodiversity and taxonomy. Wiley-Blackwell, New York, p 632
Hsieh ML, Chou CC (2006) Mutagenicity and antimutagenic effect of soymilk fermented with lactic acid bacteria and bifidobacteria. Int J Food Microbiol 111:43–47
Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Setoyama H, Hara T, Umesaki Y (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 14:2511–2516
Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaok AI, Otani T (2003) Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 22:56–63
Isolauri E (2004) Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep 4:270–275
Isolauri E, Sutas Y, Kankaanpa P, Arvilommi H, Salminen S (2001) Probiotics: effects on immunity. Am J Clin Nutr 73:444–450
Khulusi S, Mendall MA, Patel P, Levy J, Badve S, Northfield TC (1995) Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 37:319–324
Kiatpapan P, Yamashita M, Kawaraichi N, Yasuda T, Murooka Y (2001) Heterologous expression of a gene encoding cholesterol oxidase in probiotic strains of Lactobacillus plantarum and Propionibacterium freudenreichii under the control of native promoters. J Biosci Bioeng 92:459–465
Koletzko S (2016) Probiotics and prebiotics for prevention of food allergy: indications and recommendations by societies and institutions. J Pediatr Gastroenterol Nutr 63:9–10
Kwak SH, Cho YM, Noh GM, Om AS (2014) Cancer preventive potential of kimchi lactic acid bacteria (Weissella cibaria, Lactobacillus plantarum). J Cancer Prevent 19:253–258
Lee NK, Kim SY, Han KJ, Eom SJ, Paik HD (2014) Probiotic potential of Lactobacillus strains with anti-allergic effects from kimchi for yogurt starters. LWT Food Sci Tech 58:130–134
Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh W (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115:1–4
Lollo PCB, de Moura CS, Morato PN, Cruz AG, de Freitas CW, Betim CB, Nisishima L, Faria JAF, Junior MM, Fernandes CO, Amaya-Farfan J (2013) Probiotic yogurt offers higher immune-protection than probiotic whey beverage. Food Res Int 54:118–124
Macouzet M, Lee BH, Robert N (2009) Production of conjugate linoleic acid by probiotic Lactobacillus acidophilus La-5. J Appl Microbiol 106:1886–1891
Metchnikoff E (1907) The prolongation of life. Optimistic studies London, pp 16–183
Mohan R, Koebnick C, Schildt J, Mueller M, Radke M, Blaut M (2008) Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatric Res 64:418–422
Mohania D, Kansal VK, Sagwal R, Shah D (2013) Anticarcinogenic effect of probiotic dahi and piroxicam on DMH-induced colorectal carcinogenesis in Wister rats. Am J Cancer Ther Pharmacol 1:8–24
Nguyen TD, Kang JH, Lee MS (2007) Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 113:358–361
Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden N, Smidt H, Kimpen J, Hoekstr M (2009) The effects of selected probiotic strains on the development of eczema (the P and a study). Allergy 64:1349–1358
Ollech JE, Shen NT, Crawford CV, Ringel Y (2016) Use of probiotics in prevention and treatment of patients with Clostridium difficile infection. 30:111–118
Ouwehand AC, Salminen S, Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwen 82:279–289
Parracho H, McCartney AL, Gibson GR (2007) Probiotics and prebiotics in infant nutrition. Proc Nutr Soc 66:405–411
Patel S, Shukla R, Goyal A (2015) Probiotics in valorization of innate immunity across various animal models. J Func Foods 14:549–561
Pedrosa MC, Golner BB, Goldin BR, Barakat S, Dallal GE, Russell RM (1995) Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am J Clin Nutr 61:353–359
Plummer M, Franceschi S, Munoz N (2004) Epidemiology of gastric cancer. IARC Sci Publ 157:311–326
Ranadheera R, Baines S, Adams M (2010) Importance of food in probiotic efficacy. Food Res Int 43:1–7
Reid G (2016) Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gasteroenterol 30:17–25
Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D (2005) Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunol 115:441–450
Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P (2013) An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol 50:1–16
Sadana G, Sikri C, Sadana S (2015) Role of probiotics in general and oral health: a review. Ind J Compr Dent Care 5:571–577
Savadago A, Ouattara CAT, Bassol IHN, Traore SA (2006) Bacteriocins and lactic acid bacteria–a mini review. Afr J Biotec 5:678–683
Schulz C, Koch N, Schutte K, Pieper DH, Malfertheiner P (2015) H. pylori and its modulation of gastrointestinal microbiota. J Dig Dis 16:109–117
Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Env Microbiol 70:518–526
Shah NP (2007) Functional cultures and health benefits. Int Dairy J 17:1262–1277
Shah NP (2015) Functional properties of fermented milks. In: Tamang JP (ed) Health benefits of fermented foods. CRC Press, New York, pp 261–274
Shah NP, da Cruz AG, Faria JDAF (2013) Probiotics and probiotic foods: technology, stability and benefits to human health. Nova Science Publishers, New York
Singh PK, Shukla P (2014) Systems biology as an approach for deciphering microbial interactions. Brief Func Genomics 14:166–168
Song X, Hu X, Ji P, Li Y, Chi G, Song Y (2012) Phytoremediation of cadmium-contaminated farmland soil by the hyperaccumulator beta vulgaris L. Var. Cicla. Bull Environ Contam Toxicol 88:623–626
Vanderhoof JA (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30:34–38
Vasiljevic T, Shah NP (2008) Probiotics-from Metchnikoff to bioactives. Int Dairy J 18:714–728
Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM (2004) Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 80:737–741
Won TJ, Kim B, Song DS, Lim YT, Oh ES, Lee DI, Park ES, Min H, Park SY, Hwang KW (2011) Modulation of Th1/Th2 balance by Lactobacillus strains isolated from kimchi via stimulation of macrophage cell line J774A.1 in vitro. J Food Sci 76:55–61
Xiao J, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosono A (2003) Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86:2452–2461
Yadav R, Shukla P (2015) An overview of advanced technologies for selection of probiotics and their expediency: a review. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2015.1108957
Yanping W, Nv X, Aodeng X, Zaheer A, Bin Z, Xiaojia B (2009) Effect of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. App Microbiol Biotechnol 84:341–347
Zhang L, Li N, Caicedo R, Neu J (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135:1752–1756
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yadav, R., Shukla, P. (2017). Probiotics for Human Health: Current Progress and Applications. In: Shukla, P. (eds) Recent advances in Applied Microbiology . Springer, Singapore. https://doi.org/10.1007/978-981-10-5275-0_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-5275-0_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5274-3
Online ISBN: 978-981-10-5275-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)